ID   SC5A7_HUMAN             Reviewed;         580 AA.
AC   Q9GZV3; Q53TF2;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 127.
DE   RecName: Full=High affinity choline transporter 1;
DE   AltName: Full=Hemicholinium-3-sensitive choline transporter;
DE            Short=CHT;
DE   AltName: Full=Solute carrier family 5 member 7;
GN   Name=SLC5A7; Synonyms=CHT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Spinal cord;
RX   PubMed=11027560; DOI=10.1006/bbrc.2000.3561;
RA   Apparsundaram S., Ferguson S.M., George A.L. Jr., Blakely R.D.;
RT   "Molecular cloning of a human, hemicholinium-3-sensitive choline
RT   transporter.";
RL   Biochem. Biophys. Res. Commun. 276:862-867(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=11068039; DOI=10.1016/S0014-5793(00)02134-7;
RA   Okuda T., Haga T.;
RT   "Functional characterization of the human high-affinity choline
RT   transporter.";
RL   FEBS Lett. 484:92-97(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Hypothalamus;
RA   Wieland A., Bonisch H., Bruess M.;
RT   "Molecular cloning of the human and murine high affinity choline
RT   transporters and characterization of the human gene structure.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH SEC14L1.
RX   PubMed=17092608; DOI=10.1016/j.neuint.2006.09.010;
RA   Ribeiro F.M., Ferreira L.T., Marion S., Fontes S., Gomez M.,
RA   Ferguson S.S., Prado M.A., Prado V.F.;
RT   "SEC14-like protein 1 interacts with cholinergic transporters.";
RL   Neurochem. Int. 50:356-364(2007).
RN   [7]
RP   INVOLVEMENT IN HMN7A.
RX   PubMed=23141292; DOI=10.1016/j.ajhg.2012.09.019;
RA   Barwick K.E., Wright J., Al-Turki S., McEntagart M.M., Nair A.,
RA   Chioza B., Al-Memar A., Modarres H., Reilly M.M., Dick K.J.,
RA   Ruggiero A.M., Blakely R.D., Hurles M.E., Crosby A.H.;
RT   "Defective presynaptic choline transport underlies hereditary motor
RT   neuropathy.";
RL   Am. J. Hum. Genet. 91:1103-1107(2012).
RN   [8]
RP   TOPOLOGY, SUBUNIT, AND MUTAGENESIS OF ILE-89 AND GLU-451.
RX   PubMed=23132865; DOI=10.1074/jbc.M112.405027;
RA   Okuda T., Osawa C., Yamada H., Hayashi K., Nishikawa S., Ushio T.,
RA   Kubo Y., Satou M., Ogawa H., Haga T.;
RT   "Transmembrane topology and oligomeric structure of the high-affinity
RT   choline transporter.";
RL   J. Biol. Chem. 287:42826-42834(2012).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN CMS20, VARIANTS CMS20
RP   GLY-48; GLU-65; SER-105; HIS-111; CYS-175; THR-291; LEU-344; GLN-361;
RP   VAL-418 AND GLY-446, AND CHARACTERIZATION OF VARIANTS CMS20 GLY-48;
RP   GLU-65; SER-105; GLN-361 AND GLY-446.
RX   PubMed=27569547; DOI=10.1016/j.ajhg.2016.06.033;
RA   Bauche S., O'Regan S., Azuma Y., Laffargue F., McMacken G.,
RA   Sternberg D., Brochier G., Buon C., Bouzidi N., Topf A., Lacene E.,
RA   Remerand G., Beaufrere A.M., Pebrel-Richard C., Thevenon J.,
RA   El Chehadeh-Djebbar S., Faivre L., Duffourd Y., Ricci F., Mongini T.,
RA   Fiorillo C., Astrea G., Burloiu C.M., Butoianu N., Sandu C.,
RA   Servais L., Bonne G., Nelson I., Desguerre I., Nougues M.C., Boeuf B.,
RA   Romero N., Laporte J., Boland A., Lechner D., Deleuze J.F.,
RA   Fontaine B., Strochlic L., Lochmuller H., Eymard B., Mayer M.,
RA   Nicole S.;
RT   "Impaired presynaptic high-affinity choline transporter causes a
RT   congenital myasthenic syndrome with episodic apnea.";
RL   Am. J. Hum. Genet. 99:753-761(2016).
RN   [10]
RP   VARIANT VAL-89.
RX   PubMed=12237312; DOI=10.1074/jbc.M207742200;
RA   Okuda T., Okamura M., Kaitsuka C., Haga T., Gurwitz D.;
RT   "Single nucleotide polymorphism of the human high affinity choline
RT   transporter alters transport rate.";
RL   J. Biol. Chem. 277:45315-45322(2002).
CC   -!- FUNCTION: Transmembrane transporter that imports choline from the
CC       extracellular space into the neuron with high affinity. Choline
CC       uptake is the rate-limiting step in acetylcholine synthesis.
CC       Sodium ion- and chloride ion-dependent.
CC       {ECO:0000269|PubMed:11027560, ECO:0000269|PubMed:27569547}.
CC   -!- SUBUNIT: Homooligomerizes at cell surface (PubMed:23132865).
CC       Interacts with SEC14L1; may regulate SLC5A7 (PubMed:17092608).
CC       {ECO:0000269|PubMed:17092608, ECO:0000269|PubMed:23132865}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11027560};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11027560}. Cell
CC       membrane {ECO:0000269|PubMed:27569547}. Cell junction, synapse
CC       {ECO:0000269|PubMed:27569547}. Note=Localized at the neuromuscular
CC       junction. {ECO:0000269|PubMed:27569547}.
CC   -!- TISSUE SPECIFICITY: Expressed in putamen, spinal cord and medulla.
CC       Specific for cholinergic neurons.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- DISEASE: Neuronopathy, distal hereditary motor, 7A (HMN7A)
CC       [MIM:158580]: A neuromuscular disorder. Distal hereditary motor
CC       neuronopathies constitute a heterogeneous group of neuromuscular
CC       disorders caused by selective degeneration of motor neurons in the
CC       anterior horn of the spinal cord, without sensory deficit in the
CC       posterior horn. The overall clinical picture consists of a
CC       classical distal muscular atrophy syndrome in the legs without
CC       clinical sensory loss. The disease starts with weakness and
CC       wasting of distal muscles of the anterior tibial and peroneal
CC       compartments of the legs. Later on, weakness and atrophy may
CC       expand to the proximal muscles of the lower limbs and/or to the
CC       distal upper limbs. HMN7A is characterized by onset in the second
CC       decade of progressive distal muscle wasting and weakness affecting
CC       the upper and lower limbs and resulting in walking difficulties
CC       and hand grip. There is significant muscle atrophy of the hands
CC       and lower limbs. The disorder is associated with vocal cord
CC       paresis due to involvement of the tenth cranial nerve.
CC       {ECO:0000269|PubMed:23141292}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 20, presynaptic (CMS20)
CC       [MIM:617143]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness. CMS20 is an autosomal recessive,
CC       pre-synaptic form characterized by severe hypotonia and episodic
CC       apnea soon after birth, generalized limb fatigability and
CC       weakness, delayed walking, ptosis, poor sucking and swallowing.
CC       {ECO:0000269|PubMed:27569547}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Specifically inhibited by nanomolar concentrations
CC       of hemicholinium 3.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF)
CC       (TC 2.A.21) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF276871; AAG25940.1; -; mRNA.
DR   EMBL; AB043997; BAB18161.1; -; mRNA.
DR   EMBL; AJ401466; CAC03717.1; -; mRNA.
DR   EMBL; AJ308378; CAC88115.1; -; Genomic_DNA.
DR   EMBL; AJ308379; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308380; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308381; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308382; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308383; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308384; CAC88115.1; JOINED; Genomic_DNA.
DR   EMBL; AC009963; AAY14927.1; -; Genomic_DNA.
DR   EMBL; BC111525; AAI11526.1; -; mRNA.
DR   CCDS; CCDS2074.1; -.
DR   PIR; JC7502; JC7502.
DR   RefSeq; NP_001291934.1; NM_001305005.2.
DR   RefSeq; NP_068587.1; NM_021815.4.
DR   UniGene; Hs.287758; -.
DR   ProteinModelPortal; Q9GZV3; -.
DR   BioGrid; 121915; 2.
DR   STRING; 9606.ENSP00000264047; -.
DR   BindingDB; Q9GZV3; -.
DR   ChEMBL; CHEMBL4507; -.
DR   DrugBank; DB00122; Choline.
DR   GuidetoPHARMACOLOGY; 914; -.
DR   TCDB; 2.A.21.8.2; the solute:sodium symporter (sss) family.
DR   iPTMnet; Q9GZV3; -.
DR   PhosphoSitePlus; Q9GZV3; -.
DR   BioMuta; SLC5A7; -.
DR   DMDM; 56404957; -.
DR   EPD; Q9GZV3; -.
DR   PaxDb; Q9GZV3; -.
DR   PeptideAtlas; Q9GZV3; -.
DR   PRIDE; Q9GZV3; -.
DR   Ensembl; ENST00000264047; ENSP00000264047; ENSG00000115665.
DR   Ensembl; ENST00000409059; ENSP00000387346; ENSG00000115665.
DR   GeneID; 60482; -.
DR   KEGG; hsa:60482; -.
DR   UCSC; uc002tdv.4; human.
DR   CTD; 60482; -.
DR   DisGeNET; 60482; -.
DR   GeneCards; SLC5A7; -.
DR   HGNC; HGNC:14025; SLC5A7.
DR   HPA; HPA046105; -.
DR   MalaCards; SLC5A7; -.
DR   MIM; 158580; phenotype.
DR   MIM; 608761; gene.
DR   MIM; 617143; phenotype.
DR   neXtProt; NX_Q9GZV3; -.
DR   OpenTargets; ENSG00000115665; -.
DR   Orphanet; 139589; Distal hereditary motor neuropathy type 7.
DR   PharmGKB; PA37838; -.
DR   eggNOG; KOG3761; Eukaryota.
DR   eggNOG; COG0591; LUCA.
DR   GeneTree; ENSGT00690000101915; -.
DR   HOGENOM; HOG000016386; -.
DR   HOVERGEN; HBG054160; -.
DR   InParanoid; Q9GZV3; -.
DR   KO; K14387; -.
DR   OMA; HAKYQKP; -.
DR   OrthoDB; EOG091G050W; -.
DR   PhylomeDB; Q9GZV3; -.
DR   TreeFam; TF314588; -.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-425366; Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds.
DR   GeneWiki; Choline_transporter; -.
DR   GenomeRNAi; 60482; -.
DR   PRO; PR:Q9GZV3; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115665; -.
DR   CleanEx; HS_SLC5A7; -.
DR   Genevisible; Q9GZV3; HS.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0033265; F:choline binding; IBA:GO_Central.
DR   GO; GO:0015220; F:choline transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0005307; F:choline:sodium symporter activity; IMP:MGI.
DR   GO; GO:0008292; P:acetylcholine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007269; P:neurotransmitter secretion; TAS:Reactome.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   Pfam; PF00474; SSF; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Congenital myasthenic syndrome; Disease mutation; Glycoprotein;
KW   Ion transport; Membrane; Neurodegeneration;
KW   Neurotransmitter biosynthesis; Phosphoprotein; Polymorphism;
KW   Reference proteome; Sodium; Sodium transport; Symport; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    580       High affinity choline transporter 1.
FT                                /FTId=PRO_0000105391.
FT   TOPO_DOM      1      6       Extracellular. {ECO:0000255}.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TOPO_DOM     28     48       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TOPO_DOM     70     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical. {ECO:0000255}.
FT   TOPO_DOM    103    125       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    126    146       Helical. {ECO:0000255}.
FT   TOPO_DOM    147    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical. {ECO:0000255}.
FT   TOPO_DOM    186    191       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    192    212       Helical. {ECO:0000255}.
FT   TOPO_DOM    213    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TOPO_DOM    259    274       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    275    295       Helical. {ECO:0000255}.
FT   TOPO_DOM    296    317       Extracellular. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical. {ECO:0000255}.
FT   TOPO_DOM    339    376       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    377    397       Helical. {ECO:0000255}.
FT   TOPO_DOM    398    406       Extracellular. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical. {ECO:0000255}.
FT   TOPO_DOM    428    435       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    436    456       Helical. {ECO:0000255}.
FT   TOPO_DOM    457    481       Extracellular. {ECO:0000255}.
FT   TRANSMEM    482    502       Helical. {ECO:0000255}.
FT   TOPO_DOM    503    580       Cytoplasmic. {ECO:0000255}.
FT   REGION      502    580       Mediates interaction with SEC14L1.
FT                                {ECO:0000250|UniProtKB:Q9JMD7}.
FT   CARBOHYD    301    301       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      48     48       D -> G (in CMS20; decreased choline
FT                                transmembrane transporter activity; no
FT                                effect on localization at plasma
FT                                membrane). {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077854.
FT   VARIANT      65     65       G -> E (in CMS20; loss of choline
FT                                transmembrane transporter activity; no
FT                                effect on localization at plasma
FT                                membrane). {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077855.
FT   VARIANT      89     89       I -> V (40% reduction in choline uptake
FT                                rate; found in 0.06 of Ashkenazi Jews;
FT                                dbSNP:rs1013940).
FT                                {ECO:0000269|PubMed:12237312}.
FT                                /FTId=VAR_020524.
FT   VARIANT     105    105       P -> S (in CMS20; decreased choline
FT                                transmembrane transporter activity; no
FT                                effect on localization at plasma
FT                                membrane). {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077856.
FT   VARIANT     111    111       Y -> H (in CMS20; no effect on
FT                                localization at plasma membrane).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077857.
FT   VARIANT     175    175       Y -> C (in CMS20; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077858.
FT   VARIANT     291    291       I -> T (in CMS20; unknown pathological
FT                                significance; dbSNP:rs375397889).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077859.
FT   VARIANT     344    344       V -> L (in CMS20; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077860.
FT   VARIANT     361    361       R -> Q (in CMS20; decreased choline
FT                                transmembrane transporter activity; no
FT                                effect on localization at plasma
FT                                membrane; dbSNP:rs147656110).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077861.
FT   VARIANT     418    418       F -> V (in CMS20; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077862.
FT   VARIANT     446    446       R -> G (in CMS20; decreased choline
FT                                transmembrane transporter activity; no
FT                                effect on localization at plasma
FT                                membrane). {ECO:0000269|PubMed:27569547}.
FT                                /FTId=VAR_077863.
FT   MUTAGEN      89     89       I->A: Only 20% of wild-type choline
FT                                uptake activity.
FT                                {ECO:0000269|PubMed:23132865}.
FT   MUTAGEN     451    451       E->Q: Only 5% of wild-type choline uptake
FT                                activity. {ECO:0000269|PubMed:23132865}.
SQ   SEQUENCE   580 AA;  63204 MW;  66CB35496CB6E2D6 CRC64;
     MAFHVEGLIA IIVFYLLILL VGIWAAWRTK NSGSAEERSE AIIVGGRDIG LLVGGFTMTA
     TWVGGGYING TAEAVYVPGY GLAWAQAPIG YSLSLILGGL FFAKPMRSKG YVTMLDPFQQ
     IYGKRMGGLL FIPALMGEMF WAAAIFSALG ATISVIIDVD MHISVIISAL IATLYTLVGG
     LYSVAYTDVV QLFCIFVGLW ISVPFALSHP AVADIGFTAV HAKYQKPWLG TVDSSEVYSW
     LDSFLLLMLG GIPWQAYFQR VLSSSSATYA QVLSFLAAFG CLVMAIPAIL IGAIGASTDW
     NQTAYGLPDP KTTEEADMIL PIVLQYLCPV YISFFGLGAV SAAVMSSADS SILSASSMFA
     RNIYQLSFRQ NASDKEIVWV MRITVFVFGA SATAMALLTK TVYGLWYLSS DLVYIVIFPQ
     LLCVLFVKGT NTYGAVAGYV SGLFLRITGG EPYLYLQPLI FYPGYYPDDN GIYNQKFPFK
     TLAMVTSFLT NICISYLAKY LFESGTLPPK LDVFDAVVAR HSEENMDKTI LVKNENIKLD
     ELALVKPRQS MTLSSTFTNK EAFLDVDSSP EGSGTEDNLQ
//
